Japanese encephalitis

Japanese Encephalitis (JE) Overview

Japanese encephalitis is a mosquito-borne viral disease that affects the brain, causing inflammation and potentially leading to severe symptoms or death.

• Transmission: The virus is primarily spread through the bite of an infected Culex mosquito, which is most active at dusk and dawn. [1][2]
• Symptoms: Most people (more than 99%) infected with Japanese encephalitis virus do not have symptoms or have only mild symptoms. However, some people may develop inflammation of the brain, with symptoms including:
  • Severe headache
  • Feeling confused
  • Paralysis (inability to feel or move parts of the body)
  • Seizures (fits) [3][4]
• Severity: In severe cases, symptoms can include rapid onset of high fever, headache, neck stiffness, disorientation, and sometimes seizures. Up to one third of patients with encephalitis may experience these severe symptoms. [5][6]
• Mortality Rate: Among patients who develop encephalitis (inflammation of the brain), about 1 in 4 (20–30%) die. [7]

Prevention and Control

While there is no specific treatment for Japanese encephalitis, prevention measures can be taken to reduce the risk of infection:

• Vaccination: Vaccination is recommended for some travelers to areas where JE is common.
• Mosquito Bite Prevention: Avoiding mosquito bites in endemic rural areas, particularly those close to irrigated rice fields and pig farms, can also help prevent the spread of the disease. [8]

**

Overview of Signs and Symptoms

Japanese encephalitis (JE) is a viral infection that can cause a range of symptoms, from mild to severe. Most people who contract JE do not experience any symptoms or have only mild symptoms, but in some cases, the virus can lead to serious complications.

Common Symptoms

• Mild symptoms: Fever and headache are the most common symptoms of JE, affecting approximately 1 in 250 people infected with the virus.
• Severe symptoms: In severe cases, symptoms may include:
  • Neck stiffness
  • Disorientation
  • Tremors
  • Vomiting
  • Seizures (fits)
  • Paralysis (generalized)
  • Hypertonia
  • Loss of coordination

Incubation Period

The incubation period for JE is typically 4-14 days, during which time the virus can spread through mosquito bites.

Symptom Onset

Symptoms may appear about 5 to 15 days after being bitten by a JEV-infected mosquito.

Prevalence of Symptoms

• Most people (more than 99%) infected with Japanese encephalitis virus do not have symptoms or have only mild symptoms.
• Less than 1% of people infected develop neurologic illness, and among patients who develop encephalitis, about 1 in 4 (20-30%) die.

References

• [1] Most JEV infections are mild (fever and headache) or without apparent symptoms, but approximately 1 in 250 infections results in severe clinical illness. (Source: Search result 1)
• [2] Japanese encephalitis virus is primarily spread by mosquitoes. Learn about areas at risk, the illness it causes, and ways to prevent becoming infected, including vaccination. (Source: Search result 2)
• [3] While most infections result in little or no symptoms, occasional inflammation of the brain occurs. In these cases, symptoms may include headache, vomiting, fever, confusion, and seizures. This occurs about 5 to 15 days after infection. (Source: Search result 12)

Diagnostic Tests for Japanese Encephalitis

Japanese encephalitis (JE) is a viral infection that can cause severe illness, including meningitis and encephalitis. Diagnosing JE requires a combination of clinical examination, laboratory tests, and sometimes, imaging studies.

Laboratory Tests:

• Immunoglobulin M (IgM) antibody capture ELISA: This test detects the presence of IgM antibodies in serum or cerebrospinal fluid (CSF), indicating recent infection [1].
• Capture immunoassay methodology: This method demonstrates IgM antibody in CSF or serum, supporting a diagnosis of JE [3].
• Hemagglutination (HI) test: Although widely used for JE diagnosis, this test has cross-reactivity with other flaviviruses and requires sera to be first tested for other viruses [4].

Clinical Examination:

• Initial diagnosis can be made by clinical examination, followed by a lumbar puncture to collect CSF samples [5].
• Japanese encephalitis virus infection can result in febrile illness or neurologic disease, including meningitis or encephalitis [6].

Sample Collection and Preparation:

• EDTA blood is the preferred sample type for JE diagnosis, as recommended by ACDP [8].
• Blood samples should be collected using EDTA tubes to prevent clotting and ensure accurate test results.

Molecular and Biophysical Methods:

• Laboratory-based tests and clinical methods are used to confirm JE virus infection [7].

In summary, diagnosing Japanese encephalitis requires a combination of laboratory tests, including IgM antibody capture ELISA, capture immunoassay methodology, and HI test, along with clinical examination and sample collection using EDTA blood tubes.

References: [1] Solomon T. (1998) [3] Apr 6, 2023 [4] Apr 6, 2023 [5] Aug 6, 2024 [6] May 15, 2024 [7] RK Upadhyay. (2013) [8] Mar 29, 2022

Current Status of Drug Treatment for Japanese Encephalitis

Unfortunately, there is no specific antiviral drug approved for the treatment of Japanese encephalitis (JE) [6]. While vaccines are available to prevent JE, they may not cover all at-risk individuals and do not provide a cure for those already infected.

Supportive Care

Clinical management of JE is primarily supportive, focusing on relieving symptoms and preventing complications. Patients with JE should be closely monitored for severe complications, such as meningitis or encephalitis [10]. Supportive care may include:

• Rest
• Fluids to prevent dehydration
• Pain medications, such as acetaminophen (paracetamol), to reduce fever and relieve headache or body aches [4]
• Medications to manage fluid balance and prevent intracranial pressure [9]

Experimental Treatments

Researchers have explored various experimental treatments for JE, including:

• Minocycline, an antibiotic that has shown potential in reducing inflammation and improving recovery rates [11]
• Temoporfin, niclosamide, nitazoxanide, berbamine, and fenofibrate, which have been repurposed as potential therapeutic agents against JE [13]

Challenges Ahead

The lack of a specific antiviral treatment for JE highlights the need for further research into effective treatments. The development of new therapies or the repurposing of existing ones could potentially improve outcomes for patients with JE.

References:

[4] Medications for fever and pain relief: Acetaminophen (paracetamol) may be given to reduce fever and relieve headache or body aches. [6] by C Yin · 2024 · Cited by 1 — Currently, there is no specific antiviral drug approved for the treatment of JE. [9] Apr 6, 2023 — Mannitol is recommended by some experts to help reduce intracranial pressure. [10] Japanese encephalitis virus infection can result in febrile illness or neurologic disease, including meningitis or encephalitis. If you think you or a family member might have Japanese encephalitis, talk with your healthcare provider. [11] MSC treatment itself has a beneficial effect in terms of improved recovery rate from JE in a mouse model. [13] Drug repurposing, which has become a popular and convenient drug discovery method, intends to uncover new therapeutic properties of old drugs.

Differential Diagnoses of Japanese Encephalitis

Japanese encephalitis (JE) is a mosquito-borne flavivirus that can cause severe neurological symptoms, including meningitis and encephalitis. When diagnosing JE, it's essential to consider other differential diagnoses that may present similar symptoms.

Other Diseases to Consider:

• West Nile virus encephalitis: This disease is also transmitted by mosquitoes and can cause fever, headache, and encephalitis.
• St. Louis encephalitis: Another mosquito-borne flavivirus, St. Louis encephalitis can cause symptoms similar to JE, including fever, headache, and encephalitis.
• Murray Valley encephalitis: This disease is also transmitted by mosquitoes and can cause symptoms such as fever, headache, and encephalitis.

Key Points:

• A careful travel history is crucial in diagnosing JE, as the virus is primarily found in Asia and the Western Pacific.
• Only 1% of patients infected with the JEV will progress to encephalitis, and unfortunately, mortality for patients who do develop encephalitis is 20% to 30%.
• There is no specific treatment for Japanese encephalitis.

References:

• [3] JE should be considered in a patient with evidence of a neurologic infection (e.g., meningitis, encephalitis, or acute flaccid paralysis) who has recently traveled to or resided in an area at risk for JE in Asia or the Western Pacific.
• [11] Differential diagnoses include West Nile virus encephalitis, St. Louis encephalitis, Murray Valley encephalitis
• [14] Vaccination may be preventive in endemic areas, although infection with Japanese encephalitis confers lifelong immunity.